Evaluation of physicians' knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process

BACKGROUND : Polypharmacy is a common global health concern in the older population. Deprescribing has been acknowledged as an important aspect of medication use review that helps to reduce polypharmacy, inappropriate medication uses and medication adverse events, thus ensuring medication optimizati...

Full description

Saved in:
Bibliographic Details
Published in:BMC family practice 2023-01, Vol.24 (1), p.31-31, Article 31
Main Authors: Akande-Sholabi, Wuraola, Ajilore, Comfort O, Ilori, Temitope
Format: Article
Language:English
Subjects:
Beers Criteria
Cross-Sectional Studies
Data collection
Deprescribing
Deprescriptions
Drug formularies
Evaluation
Health care
Humans
Knowledge
Likert scale
Medicine
Older adults
Older people
Participation
Patients
Physicians
Polypharmacy
Potentially Inappropriate Medication List
Practice
Prescription writing
Psychiatry
Quality of Life
Questionnaires
Response rates
Sample size
Teaching hospitals
University colleges
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND : Polypharmacy is a common global health concern in the older population. Deprescribing has been acknowledged as an important aspect of medication use review that helps to reduce polypharmacy, inappropriate medication uses and medication adverse events, thus ensuring medication optimization and improving health-related quality of life. As physicians are primarily responsible for prescribing and monitoring of drug therapy, their perception of deprescribing and knowledge of available deprescribing tools is highly important. This study aimed to explore physicians' knowledge of deprescribing, deprescribing tools and factors that may affect the deprescribing process. This was a cross-sectional survey carried out among 70 physicians in selected units of a teaching hospital in Nigeria between May and June 2022. Social-demographic information, knowledge of deprescribing and deprescribing tools were obtained using a self-administered, semi-structured questionnaire, while barriers and enablers of medication deprescribing were assessed with modified Revised Patients' Attitudes Towards Deprescribing (rPATD) Questionnaire. Descriptive and bivariate analyses were carried out using SPSS and α was set at p 
ISSN:2731-4553
2731-4553
1471-2296
DOI:10.1186/s12875-023-01990-1